DelveInsight's B-cell Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast report includes a comprehensive understanding of current treatment practices, addressable ...

A new study identifies eight domains of active systemic #lupus erythematosus for defining meaningful treatment response in ...

(MENAFN- GlobeNewsWire - Nasdaq) Clinical Trials of Budoprutug in Primary Membranous Nephropathy (pMN), Immune Thrombocytopenia (ITP), and Systemic Lupus Erythematosus (SLE) on Track to Initiate ...

2 In this article, the authors’ effort to translate the disease activity in SLE into a more responsive score by quantifying arthritis, proteinuria, leucopenia and thrombocytopenia seems promising.

Our purpose was to compile information on the haematological manifestations of systemic lupus erythematosus (SLE), namely leucopenia, lymphopenia, thrombocytopenia, autoimmune haemolytic anaemia (AIHA ...

The researchers identified several significant predictors of SLE flares during pregnancy ... treatment regimen data and variability in disease flare definitions and thrombocytopenia and ...

Sickle cell disease (SCD) with concurrent systemic lupus erythematosus (SLE) is an uncommon but significant association ... Leukopenia occurred in 41.6% of patients, and thrombocytopenia occurred in ...

This case and another recently published case of SLE-associated secondary immune thrombocytopenia 10 illustrate the potential of CAR T cells as a therapeutic option for multi-refractory primary and ...

Petrolheads often spend hours on end poring over the latest models from their favorite manufacturers. As much fun as it is salivating over their specs and considering the virtues of different ...

Objectives Diagnostic reasoning in systemic lupus erythematosus (SLE) is a complex process reflecting the probability of disease at a given timepoint against competing diagnoses. We applied machine ...

One mid-stage study will be using TNT119 to treat patients with systemic lupus erythematosus [SLE] and then the other mid-stage trial is going to target patients with immune thrombocytopenia [ITP].

In addition, the potential use of CM313 in SLE is currently under clinical development ...